Literature DB >> 10329832

Pharmacologic regulation of histamine release by the human recombinant histamine-releasing factor.

R Bheekha-Escura1, S R Chance, J M Langdon, D W MacGlashan, S M MacDonald.   

Abstract

BACKGROUND: The recently cloned human recombinant IgE-dependent histamine releasing factor (HrHRF) was initially thought to stimulate histamine release from human basophils from a subpopulation of allergic donors by interacting with the IgE molecules on the surface of these cells. Additional data suggest that HrHRF exerts its biologic effects by binding to a distinct cell surface structure and not to IgE.
OBJECTIVE: To address the hypothesis that the HrHRF signaling pathway is distinct from the classical high-affinity IgE receptor (FcepsilonRI) pathway, we used pharmacologic agents known to affect basophil histamine release.
METHODS: In this report we compared the effect of staurosporine, Bis II, Gö 6976, rottlerin, and pertussis toxin on histamine release from human basophils mediated by the following stimuli: HrHRF, polyclonal human anti-IgE antibody, and antigen, as well as the IgE-independent stimulus, FMLP.
RESULTS: None of these modulators, except rottlerin, could differentiate histamine release induced by anti-IgE or antigen from that induced by HrHRF. Rottlerin enhanced HrHRF-mediated histamine release and dose dependently blocked FMLP-mediated release without affecting basophil activation by either anti-IgE or antigen.
CONCLUSION: These data suggest a unique signaling pathway for HrHRF and thus strengthen the hypothesis that HrHRF binds to a specific receptor other than IgE.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329832     DOI: 10.1016/s0091-6749(99)70442-2

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  7 in total

Review 1.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

2.  Expression of immunoglobulin E-dependent histamine-releasing factor in idiopathic nephrotic syndrome of childhood.

Authors:  S Toyabe; U Kaneko; M Hara; M Uchiyama
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

Review 3.  An overview of chronic urticaria.

Authors:  Vincent S Beltrani
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

4.  The effects of overexpression of histamine releasing factor (HRF) in a transgenic mouse model.

Authors:  Yueh-Chiao Yeh; Liping Xie; Jacqueline M Langdon; Allen C Myers; Sun-Young Oh; Zhou Zhu; Susan M Macdonald
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

5.  Distinct characteristics of signal transduction events by histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced priming and activation of human basophils.

Authors:  Becky M Vonakis; Donald W Macglashan; Natalia Vilariño; Jacqueline M Langdon; Rebecca S Scott; Susan M MacDonald
Journal:  Blood       Date:  2007-11-27       Impact factor: 22.113

6.  Potential role of histamine releasing factor (HRF) as a therapeutic target for treating asthma and allergy.

Authors:  Susan M Macdonald
Journal:  J Asthma Allergy       Date:  2012-09-17

7.  Dimerized translationally controlled tumor protein increases interleukin-8 expression through MAPK and NF-κB pathways in a human bronchial epithelial cell line.

Authors:  Heewon Lee; Kyunglim Lee
Journal:  Cell Biosci       Date:  2018-02-20       Impact factor: 7.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.